Enforcement Report for Week of August 7, 2024
Enforcement Report - Week of July 5, 2023
Health Canada Issues Recall of Ferring`s Endometrin effervescent vaginal tablets
Enforcement Report - Week of February 1, 2023
The Scottish Medicines Consortium (SMC) has approved Utrogestan, the only adjunctive micronised progesterone available as hormone replacement therapy (HRT) for use alongside any oestrogen-only HRT for women with an intact uterus.
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the Second Quarter ended June 30, 2022.
Xiromed's Generic Progesterone Receives Approval in the U.S.
Enforcement Report - Week of November 17, 2021
Pfizer’s contract development and manufacturing organization (CDMO) is now offering services in Nagoya, Japan.
Theramex has recently launched the first and only body-identical hormone therapy treatment (HRT) for post-menopausal women, in the form of Bijuva/Bijuve® (estradiol and progesterone).